Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery

Vascular Pharmacology

Volumn 44, Issue 5, 2006, Pages 363-371

  Kennedy, Simon ^a   Wadsworth, Roger M ^a   Wainwright, Cherry L ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

Antiproliferative; Balloon injury; Restenosis; Vascular contraction; Vascular relaxation

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; CALCIMYCIN; DECAHYDRO 1,1,4,7 TETRAMETHYL 1H CYCLOPROP[E]AZULEN 4 2 [2 (3 METHYLPENT 2 ENOYL)FUCOPYRANOSIDE; LINSIDOMINE; PACLITAXEL; POTASSIUM CHLORIDE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PYRANOSIDE; RAPAMYCIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; CORONARY STENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INFUSION; DRUG INHIBITION; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE CONTRACTILITY; SWINE;

ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; AZULENES; CALCIMYCIN; CORONARY VESSELS; FUCOSE; GROWTH INHIBITORS; MALE; METHIONINE; MODELS, ANIMAL; SEROTONIN; SIROLIMUS; SWINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 33646155939     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.01.012     Document Type: Article

References (49)

1. Ambrosini A., Tininini S., Barassi A., Racagni G., Sturani E., and Zippel R. Camp cascade leads to Ras activation in cortical neurones. Mol. Brain. Res. 75 (2000) 50-60
2. Baumbach A., Herdeg C., Kluge M., Oberhoff M., Lerch M., Haase K.K., Wolter C., Schroder S., and Karsch K.R. Local drug delivery: impact of pressure, substance characteristics and stenting on drug transfer into the arterial wall. Catheter Cardiovasc. Interv. 47 (1999) 102-106
3. Bax W.A., Renzenbrink G.J., Van Heuven-Nolsen D., Thijssen E.J., Bos E., and Saxena P.R. 5-HT receptors mediating contractions of the isolated human coronary artery. Eur. J. Pharmacol. 239 (1993) 203-210
4. Corbin F., Blaise G.A., Parent M., Chen H., and Daloze P.M. Effect of rapamycin on rat aortic ring vasomotion. J. Cardiovasc. Pharmacol. 24 (1994) 813-817
5. Ferns G.A., and Avades T.Y. The mechanisms of coronary restenosis: insights from experimental models. Int. J. Exp. Pathol. 81 (2000) 63-88
6. Fonseca F.A., Izar M.C., Fuster V., Gallo R., Padurean A., Fallon J.T., Schachter E.N., Chesebro J.H., and Badimon J.J. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis 154 (2001) 61-69
7. Fournet-Bourguignon M.-P., Castedo-Delreiu M., Bidouard J.-P., Leonce S., Saboureau D., Delescluse I., Vilaine J.P., and Vanhoutte P.M. Phenotypic and functional changes occurring in regenerated coronary endothelial cells after balloon injury in the pigs. Circ. Res. 86 (2000) 854-861
8. Gomez-Alvis A., Rinaldi G., Rebolledo A., Milesi V., Sanz N., Tommasi J., and Grassi De Gende A. The antineoplastic agent paclitaxel (Taxol) increases contractile activity in human saphenous veins and human mammary arteries. Cancer Invest. 18 (2000) 327-335
9. Hausleiter J., Kastrati A., Mehilli J., Vogeser M., Schülen H., Goos C., Pache J., Dotzer F., Pogatsa-Murray G., Dirschinger J., Heeman U., Schömig A., and for the OSIRIS Investigators. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis. The oral sirolimus to inhibit recurrent in-stent restenosis (OSIRIS) trial. Circulation 110 (2004) 790-795
10. Herdeg C., Oberhoff M., Baumbach A., Blattner A., Axel D.I., Schröder S., Heinle H., and Karsch K.R. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J. Am. Coll. Cardiol. 35 (2000) 1969-1976
11. Hurley J.H., Zhang S., Bye L.S., Marshall M.S., DePaoli-Roach A.A., Guan K., Fox A.P., and Yu L. Insulin signalling inhibits the 5-HT2C receptor in choroids plexus via MAP kinase. BMC Neurosci. 9 (2003) 4-10
12. Katusic Z.S., and Vanhoutte P.M. Effects of SIN-1 on isolated canine basilar arteries. J. Cardiovasc. Pharmacol. 14 suppl. II (1989) S72-S75
13. Kauffman R.F., Bean J.S., Bloomquist W.E., and Cohen M.L. Vascular serotonin 5-hydroxytryptamine 2 receptor blockade by LY215840: lack of effect upon neointima formation in balloon-injured rat carotid arteries. J. Pharmacol. Exp. Ther. 266 (1993) 450-455
14. Kennedy S., McPhaden A.R., Wadsworth R.M., and Wainwright C.L. Correlation of leukocyte adhesiveness, adhesion molecule expression and leukocyte-induced contraction following balloon angioplasty. Br. J. Pharmacol. 130 (2000) 95-103
15. Kennedy S., Clarke B., Wadsworth R.M., and Wainwright C.L. Effect of antiproliferative agents on smooth muscle cell growth, vascular contraction and endothelium-dependent relaxation in the porcine coronary artery. Br. J. Pharmacol. 135 (2002) 310
16. Kennedy S., Fournet-Bourguignon M.-P., Breugnot C., Castedo-Delrieu M., Lesage L., Reure H., Briant C., Leonce S., Vilaine J.-P., and Vanhoutte P.M. Cells from regenerated endothelium of porcine coronary artery exhibit an increased content of oxidised forms of apo-B 100 without modification of oxidised LDL uptake. J. Vasc. Res. 40 (2003) 389-398
17. Kennedy S., Wadsworth R.M., and Wainwright C.L. Effect of antiproliferative agents on vascular function in normal and in vitro balloon-injured porcine coronary arteries. Eur. J. Pharmacol. 481 (2003) 101-107
18. Kennedy S., Preston A., McPhaden A.R., Miller A.M., Wainwright C.L., and Wadsworth R.M. Increased expression of NO synthase isoforms correlates with endothelial regeneration and development of neointima in the balloon injured rabbit subclavian artery. Coron. Artery Dis. 15 (2004) 337-346
19. Khan A., Pepio A.M., and Sossin W.S. Serotonin activates s6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes. J. Neurosci. 21 (2001) 382-391
20. Kuga T., Ohara Y., Shimokawa H., Ibayashi S., Tomoike H., and Takeshita A. Inhibitory effects of aspirin on coronary hyperreactivity to autacoids after arterial balloon injury in miniature pigs. J. Cardiovasc. Pharmacol. 25 (1995) 273-281
21. Law B.K., Norgaard P., and Moses H.L. Farnesyltransferase inhibitor induces rapid growth arrest and blocks p70s6k activation by multiple stimuli. J. Biol. Chem. 275 (2000) 10796-10801
22. Lippolis L., Sorrentino R., Popolo A., Maffia P., Nasti C., di Villa Bianca R., Marzocco S., Autore G., and Pinto A. Time course of vascular reactivity to contracting agents after endothelial denudation by balloon angioplasty in rat carotid artery. Atherosclerosis 171 (2003) 171-179
23. Liu Y., and Fanburh B.L. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of PI3K/Akt/S6K1. Am. J. Respir. Cell Mol. Biol. 34 2 (2006) 182-191
24. Luscher T.F., Richard V., and Yang Z.H. Interaction between endothelium-derived nitric oxide and SIN-1 in human and porcine blood vessels. J. Cardiovasc. Pharmacol. 14 suppl II (1989) S76-S80
25. MacDonald R.L., Zhang J., and Han H. Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm. Stroke 26 (1995) 1053-1059
26. Manderson J.A., Cocks T.M., and Campbell G.R. Balloon catheter injury to rabbit carotid artery: II. Selective increase in reactivity to some vasoconstrictor drugs. Arterioscler 9 (1989) 299-307
27. Martin K.A., Rzucidlo E.M., Merenick B.L., Finagr D.C., Brown D.J., Wagner R.J., and Powell R.J. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am. J. Physiol. 286 (2004) C507-C517
28. McPhadden E.P., Bauters C., Lablanche J.M., Quandelle P., Leroy F., and Bertrand M.E. Response of human coronary arteries to seotonin after injury by coronary angioplasty. Circulation 88 (1993) 2076-2085
29. Merhi Y., Guidon R., Provost P., Leung T.-K., and Lam J.Y.T. Increase in neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplasty. Am. Heart J. 129 (1995) 445-451
30. Miyata K., Shimokawa H., Higo T., Yamawaki T., Katsumata N., Kandabashi T., Tanaka E., Takamura Y., Yogo K., Egashira K., and Takeshita A. Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model. J. Cardiovasc. Pharmacol. 35 (2000) 294-301
31. Newby A.C. An overview of the vascular response to injury: a tribute to the late Russell Ross. Toxicol. Lett. 112-113 (2000) 519-529
32. Nishijima H., Meno H., Higashi H., Yamada K., Hamanaka N., and Takeshita A. Coronary vasomotor response to acetylcholine late after angioplasty. Jpn. Circ. J. 60 (1996) 789-796
33. Oberhoff M., Kunert W., Herdeg C., Kuttner A., Kranzhofer A., Horch B., Baumbach A., and Karsch K.R. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res. Cardiol. 96 (2001) 275-282
34. Popolo A., Marzocco S., Nasti C., Lippolis L., di Villa Bianca R., Sorrentino R., Autore G., and Pinto A. Phenotypic modifications of vascular smooth muscle cells could be responsible for vascular hyporeactivity to contracting agent in mechanically injured rat carotid artery. Atherosclerosis 183 2 (2005) 213-221
35. Pullarkat S.R., Mysels D.J., Tan M., and Cowen D.S. Coupling of serotonin 5-HT1B receptors to activation of mitogen-activated protein kinase (ERK-2) and p70 S6 kinase signalling systems. J. Neurochem. 71 (1998) 1059-1067
36. Russell A., Banes A., Berlin H., Fink G.D., and Watts S.W. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-l-arginine hypertensive rat. J. Pharmacol. Exp. Ther. 303 (2002) 179-187
37. Sauro M.D., Camporesi D.A., and Sudakow R.L. The anti-tumor agent taxol, attenuates contractile activity in rat aortic smooth muscle. Life Sci. 56 (1995) 157-161
38. Shimokawa H., and Vanhoutte P.M. Angiographic determination of hyperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenerated endothelium. J. Am. Coll. Cardiol. 17 (1991) 1197-1202
39. Shimokawa H., Flavahan N.A., and Vanhoutte P.M. Natural course of the impairment of endothelium-dependent relaxation after balloon endothelium removal in porcine coronary arteries. Circ. Res. 65 (1989) 740-753
40. Signore P.E., Machan L.S., Jackson J.K., Burt H., Bromley P., Wilson J.E., and McManus B.M. Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries. J. Vasc. Interv. Radiol. 12 (2001) 79-88
41. Sobey C.G., Faraci F.M., Piegors D.J., and Heistad D.D. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke 27 (1996) 927-933
42. Tamura K., Kanazaki T., Saito Y., Otabe M., Saito Y., and Morisaki N. Serotonin (5-hydroxytryptamine, 5-HT) enhances migration of rat aortic smooth muscle cells through 5-HT2 receptors. Atherosclerosis 132 (1997) 139-143
43. Thollon C., Bidouard J.P., Cambarrat C., Delescluse I., Villeneuve N., Vanhoutte P.M., and Vilaine J.P. Alteration of endothelium-dependent hyperpolarizations in porcine coronary arteries with regenerated endothelium. Circ. Res. 84 (1999) 371-377
44. Togni M., Windecker S., Cocchia R., Wenaweser P., Cook S., Billinger M., Meier B., and Hess O.M. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J. Am. Coll. Cardiol. 46 (2005) 231-236
45. Van Domburg R.T., Saia F., and Lemos P.A. Coronary artery bypass surgery and percutaneous transluminal coronary angioplasty in patients with multivessel disease. Minerva Cardioangiol. 51 (2003) 599-608
46. Vanhoutte P.M., and Shimokawa H. Endothelium-derived relaxing factor and vasospasm. Circulation 80 (1989) 1-9
47. Wilensky R.L., March K.L., Gradus-Pizlo I., Sandusky G., Fineberg N., and Hathaway D.R. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 92 (1995) 2995-3005
48. Wilensky R.L., Selzer F., Johnston J., Laskey W.K., Klugherz B.D., Block P., Cohen H., Detre K., and Williams D.O. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry). Am. J. Cardiol. 90 (2002) 216-221
49. Work L.M., McPhaden A.R., Pyne N.J., Pyne S., Wadsworth R.M., and Wainwright C.L. Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo following porcine coronary balloon angioplasty. Circulation 104 (2001) 1538-1543